Director, HTA & Value Evidence - Rare Disease

Pfizer seeks a Director to lead HTA, Value & Evidence for Rare Disease, guiding the global health economics and outcomes research program for Hympavzi (marstacimab). You will shape evidence strategy, coordinate cross-functional input, and deliver economic models, value dossiers and patient-centered outcomes to support rapid patient access. The role partners with medical, clinical, commercial and country teams to build robust evidence across launch and lifecycle, ensuring payer readiness and